Navigation Links
FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
Date:4/21/2011

SAN FRANCISCO, April 21, 2011 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the company's oncology drug candidate, NKTR-102, has been granted orphan drug status for the treatment of women with ovarian cancer by the U.S. Food and Drug Administration (FDA).

"This designation is an important step in the overall development program for NKTR-102 and underscores our commitment to treating women with ovarian cancer," said Dr. Lorianne Masuoka, Senior Vice President and Chief Medical Officer of Nektar Therapeutics.

Nektar has a Phase 2 study ongoing for NKTR-102 that is enrolling approximately 125 patients with platinum-resistant ovarian cancer whose disease has progressed following treatment with pegylated liposomal doxorubicin (PLD) therapy.  In addition, Phase 3 planning is also underway for NKTR-102 in ovarian cancer.  For more information about clinical trials for NKTR-102, please visit the Nektar Therapeutics website at www.nektar.com or www.clinicaltrials.gov.

NKTR-102 is an investigational agent and is not approved by the FDA, the European Medicines Agency (EMA) or other Health Authorities.

About Orphan Drug Designation in the U.S.In the United States, the Orphan Drugs Act (ODA) provides for the orphan drug designation which aims to encourage the development of drugs involved in the diagnosis, prevention or treatment of a medical condition affecting fewer than 200,000 people in the country. The designation grants U.S. market exclusivity to a drug for a particular indication for a seven-year period if the sponsor complies with certain FDA specifications. Additional incentives for the sponsor include tax credits related to clinical trial expenses and a possible exemption from the FDA-user fee. The designation does not shorten the duratio
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
2. FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium
3. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
4. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
8. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
9. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
10. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
11. HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 Mettler-Toledo International Inc. (NYSE: MTD ... below are the highlights: , Sales in ... the prior year. Reported sales decreased 4% as currency ... , Net earnings per diluted share as reported (EPS) ... Adjusted EPS was $2.80 , an increase of ...
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ ... into non-exclusive Development Agreements with Dexcom, Inc. to ... pumps with the Dexcom G5 and G6 continuous ... next generation pump platform with Dexcom,s future CGM ...
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex Pharmaceuticals, ... will report its second quarter 2015 financial results on ... conference call and live webcast at 4:30 p.m. Eastern ... development programs and a general corporate update. ... Investor Relations page of the OncoGenex website at ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... MOUNTAIN VIEW, Calif., July 20, 2011 VIVUS, Inc. ... August 31, 2011, during the late breaking poster session ... Italy, Dr. Alison Pack, Associate Professor of Clinical Neurology, ... the results of a retrospective study of medical claims ...
... Reportlinker.com announces that a new market ... Orthopaedics: Market Prospects & ... http://www.reportlinker.com/p0573671/Orthopaedics-Market-Prospects-GlobalCompetition .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine Growth ... to be 5% over the period 2010-15. ...
Cached Medicine Technology:Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 2Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 3Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 4Topiramate Exposure and Birth Defect Data to be Presented at the 29th International Epilepsy Congress 5Orthopaedics: Market Prospects & Global Competition 2Orthopaedics: Market Prospects & Global Competition 3Orthopaedics: Market Prospects & Global Competition 4Orthopaedics: Market Prospects & Global Competition 5Orthopaedics: Market Prospects & Global Competition 6Orthopaedics: Market Prospects & Global Competition 7Orthopaedics: Market Prospects & Global Competition 8Orthopaedics: Market Prospects & Global Competition 9Orthopaedics: Market Prospects & Global Competition 10Orthopaedics: Market Prospects & Global Competition 11
(Date:7/31/2015)... ... July 31, 2015 , ... David Gilpin, M.D., ... to inform potential Nashville area sinus sufferers about the benefits of ... determine if someone is a good candidate for Balloon Sinuplasty. The questionnaire asks ...
(Date:7/30/2015)... ... 2015 , ... Dale Sky Jones, Executive Chancellor of Oaksterdam University , ... Professionals Expo held at the Caribe Royal All Suites Hotel and Convention Center in ... is the largest medical cannabis expo in the country and this year’s expo will ...
(Date:7/30/2015)... ... July 31, 2015 , ... On July 22nd the Bradenton Herald ... plausible solutions for controlling the heroin outbreak. Ultimately the committee expressed lack of funding, ... perpetuating the heroin crisis in North Florida. The task force has proposed to instate ...
(Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
(Date:7/30/2015)... ... ... In an effort to provide the twenty four hour continuous care desired by his ... The decision will also allow him to spend more time in the office with ... to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has always provided excellent care ...
Breaking Medicine News(10 mins):Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 2Health News:Manatee County’s Opioid Task Force Calls for More Funding and Face to Face Counseling After Overdose 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2
... Alan Mozes HealthDay Reporter , THURSDAY, Aug. 12 ... being reported among college students than a decade ago, as ... education and are open to getting help when they need ... prescription medications by students to treat psychiatric illness has also ...
... European Urology , the official journal of the European Association ... the September issue: Case Series of the month. This series ... only preliminary results. The Case Series reports on no more ... Education question with multiple choice answers is also included to ...
... Melissa Lee Phillips HealthDay Reporter , WEDNESDAY, Aug. 11 ... be treated by bone marrow stem cell transplant, a new ... treatment of other skin diseases and also for the potential of ... according to the study published in the Aug. 12 issue of ...
... has been launched to define changes in the human immune ... infection or to vaccination. Six U. S.-based Human Immune Phenotyping ... years to conduct this research. Funding for the ... Infectious Diseases (NIAID), part of the National Institutes of Health. ...
... At least a quarter of patients who have suffered ... stroke prevention medications within the first three months after being ... highest according to a new study by researchers at ... Each year, there are an estimated 180,000 recurrent strokes in ...
... State College of Medicine,s Department of Public Health Sciences ... seven years to act as the data coordinating center ... This grant is one of the largest in the ... clinical centers across the nation that conducts clinical trials ...
Cached Medicine News:Health News:College Campuses See Rise in Cases of Severe Mental Illness 2Health News:College Campuses See Rise in Cases of Severe Mental Illness 3Health News:New case series section in European Urology 2Health News:Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder 2Health News:Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder 3Health News:NIH launches effort to define markers of human immune responses 2Health News:1 in 4 stroke patients stop taking prevention medication within 3 months 2Health News:1 in 4 stroke patients stop taking prevention medication within 3 months 3Health News:1 in 4 stroke patients stop taking prevention medication within 3 months 4Health News:College Of Medicine receives $54 million grant for asthma research 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: